levodopa ethylester
a highly soluble prodrug of levodopa, may overcome the impaired absorption of regular levodopa, due mainly to a combination of levodopa's poor solubility and delayed gastric emptying
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Fietto, Luciano Gomes:
1 article
(01/2016)
|
| 2. | Freitas, Rodrigo Barros:
1 article
(01/2016)
|
| 3. | Gonçalves, Reggiani Vilela:
1 article
(01/2016)
|
| 4. | Leite, João Paulo Viana:
1 article
(01/2016)
|
| 5. | Lima, Luciana Moreira:
1 article
(01/2016)
|
| 6. | Mendonça, Bianca Gazolla:
1 article
(01/2016)
|
| 7. | Novaes, Rômulo Dias:
1 article
(01/2016)
|
| 8. | Peluzio, Maria do Carmo Gouveia:
1 article
(01/2016)
|
| 9. | Ribeiro, Andréia Queiroz:
1 article
(01/2016)
|
| 10. | Santos, Eliziária Cardoso:
1 article
(01/2016)
|
Related Diseases
| 1. | Parkinson Disease (Parkinson's Disease)
|
| 2. | Non-alcoholic Fatty Liver Disease
01/01/2016
- " Dietary intake of LEE and especially LDEE, but not EO, attenuated diet-induced NAFLD, reducing inflammatory infiltrate, steatosis, and lipid peroxidation in liver tissue. " 01/01/2016
- " After NAFLD induction, LEE, LDEE, or EO was added to the animals' diet for 4 weeks. " 01/01/2016
- " edulis bioproducts (lyophilized pulp [LEE], defatted lyophilized pulp [LDEE], and oil [EO]) on nonalcoholic fatty liver disease (NAFLD) induced by a high-fat diet (HFD) in rats. " 01/01/2016
- " edulis bioproducts were not hepatotoxic, only LDEE presented sufficient benefits to treat NAFLD in rats, possibly by its low lipid content and high amount of phenols and anthocyanins. "
|
|
Related Drugs and Biologics
Related Therapies and Procedures